It was very interesting that both the radiation oncologist and the medical oncologist each chose to emphasize as one of his updates the importance of PSA velocity in assessing the seriousness of prostate cancer. Just a few years ago, PSA velocity was acknowledged as something to consider, but it hardly ranked with the number of cores and percent of cores and the percent of each core that was cancer, let alone with the big three: baseline PSA at diagnosis, the Gleason Score, and the clinical stage.